Complement system: A key player in hepatic ischemia-reperfusion injury

Area of Science:

• Immunology
• Hepatology
• Transplantation

Background:

• Hepatic ischemia-reperfusion injury (IRI) is a significant complication in liver surgery and transplantation.
• The complement system plays a key role in mediating sterile inflammation and damage during hepatic IRI.
• Complement activation leads to the production of effector molecules that exacerbate hepatocellular dysfunction and microvascular impairment.

Purpose of the Study:

• To analyze the mechanistic role of the complement system in hepatic IRI.
• To discuss current and emerging therapeutic strategies targeting the complement pathway for liver protection.

Main Methods:

• Review of existing literature on complement activation in hepatic IRI.
• Analysis of preclinical and translational studies on complement inhibitors.
• Examination of targeted approaches including C5 inhibitors, C5aR1 antagonists, C3 inhibitors, and regulatory proteins.

Main Results:

• Complement activation, triggered by DAMPs, generates C3a, C5a, and MAC, amplifying inflammation and endothelial damage.
• Targeted complement inhibition strategies show promise in preclinical models of hepatic IRI.
• The dual role of complement in injury and regeneration necessitates precise therapeutic modulation.

Conclusions:

• The complement system is a critical mediator of hepatic IRI, making it a viable therapeutic target.
• Complement-targeted therapies hold potential for reducing liver injury but require careful balancing to preserve immune function and regeneration.
• Further research is essential to optimize complement modulation strategies for clinical application in liver disease.